Navigating Lower Cancer-Risk Nodules in High-Risk Patients With Noninvasive CyPath® Lung Testing

Join SAB for an insightful live webinar on Tuesday, June 16 at 7 PM ET: Navigating Lower Cancer-Risk Nodules in High-Risk Patients With Noninvasive CyPath® Lung Testing

As genetic, environmental, and exposure-related risks for lung cancer continue to rise, the challenge of assessing indeterminate pulmonary nodules has become increasingly complex. With lung cancer screening and surveillance now more integrated into routine care, clinicians are seeking innovative tools to support earlier diagnosis and more informed decision-making. Join moderator Dr. Robert Sussman, Pulmonologist, Summit, NJ, alongside an expert multidisciplinary panel featuring:

• Dr. Vijay K. Gunuganti – Medical Oncology & Hematology, Texas Oncology
• Dr. Reginald Carl Baptiste – Thoracic Surgeon, Christus Health
• Dr. Sai Karan Vamsi Guda – Interventional Pulmonologist, Texas Pulmonary & Critical Care Consultants, PA

This dynamic discussion will explore how CyPath® Lung — a noninvasive test utilizing flow cytometry and artificial intelligence with at-home sample collection — is being incorporated into the lung nodule care continuum to help risk-stratify patients, reduce patient anxiety, and support surgical and treatment decision-making.

Participants will gain insight into:
• How a noninvasive test with at-home sample collection can support risk stratification for patients with indeterminate pulmonary nodules
• How flow cytometry and AI identify measurable changes in the lung microenvironment associated with malignancy
• How CyPath® Lung provides pulmonologists, oncologists, and surgeons with additional clinical insight to support earlier lung cancer diagnosis and improve patient outcomes

Don’t miss this opportunity to hear from leading experts advancing innovation in lung cancer diagnostics and patient-centered care.

Sponsored by CyPath® Lung